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Introduction: Gallbladder carcinosarcomas (GBCS) are a rare type of gallbladder malignancies. 
These tumors are characterized by interlaced epithelial and mesenchymal components.  
Presentation of Case: The experience with diagnosis and follow-up of these cancers is limited 
because of the number of patients diagnosed with this tumor is so small and the tumor has a poor 
prognosis. Therefore, we present the following case report to share our experience with a 13 -month 
survival of a 55-year-old woman presenting with right flank pain and jaundice who underwent 
laparoscopic cholecystectomy with an initial diagnosis of chronic cholecystitis and later diagnosed 
with GBCS.  
Conclusion: GBCS have  poor survival rate even with successful surgical therapy due to unclear 
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Introduction 
Gallbladder carcinosarcomas (GBCS) are a rare type of gallbladder malignancies. So far, less than 
100 cases have been reported worldwide. Therefore, experience and knowledge with this disease 
are limited. GBCS are characterized by interlaced epithelial and mesenchymal components. This  
aggressive nature of GBCSs adequately explains the limited number of resectable cases  [1-5].  
Case report 
A 55-year-old woman with right flank pain and jaundice underwent stone extraction via endoscopic 
retrograde cholangiopancreatography (ERCP) at an outside center after detection of 
choledocolithiasis in abdominal ultrasonography (USG). Magnetic resonance 
cholangiopancreatography (MRCP) performed revealed mural thickening in gallbladder, multiple 
bile stones with a diameter of 1 cm, and a normal common bile duct.  
  One month after the first attack this presentation she admitted to our hospital with similar 
complaints. Ultrasound examination showed multiple stones with a mean diameter of 11 mm in 
gallbladder as well as mild  thickening in gallbladder wall. A normal common bile duct was 
visualized. A complete blood count and liver function tests were in normal limits. An elective 
laparoscopic cholecystectomy was performed. Peroperative laparoscopic exploration revealed a 
thickened gallbladder wall in addition to multiple stones in gallbladder lumen. As it was difficult to 
catch gallbladder, its content was aspirated and a huge amount of infected material was evacuated. 
A laparoscopic cholecystectomy procedure was applied without any complication with an initial 
diagnosis of chronic cholecystitis. The gallbladder was externalized from the subxiphoid trocar site. 
Macroscopically, the gallbladder wall was characterized by a thickening that was more marked in 



















Figure 1 The tumor contains a well to moderately differentiated adenocarcinoma and sarcomatous areas (H&E x 
200). 
  Pathological examination of the postoperative material revealed a 3cm tumor in fundus, 
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extending beyond serosa. Tumor contained epithelial and sarcomatous patterns (Figure 1) and on 
immunohistochemical examination it was pancytokeratin (+), P-CEA (+), and P53 (+) in epithelial 
areas (Figure 2) and vimentin (+) and P53(+)  in areas with a sarcomatous appearance ( Figure 3). 
Desmin, smooth muscle actin, S-100, CD34, and CD31 were negative. In the light of the data 







































Figure 3  Immunohistochemistry vimentin staining mainly in the  sarcomatous components and  negative 
adenocarcinomatous components (DAP x 200). 
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  The Positron Emission Tomography – Computed Tomography (PET-CT) examination was 
performed since both the surgical border was positive and the patient had possible metastases. 
PET-CT did not detect any residual tumor, metastasis, and another primary focus. Nevertheless, as 
the patient had surgical border positivity, was taken to explorative laparotomy at first month. 
Exploration of the abdomen revealed diffuse tumor deposits in gallbladder site, omentum, 
subxiphoid trocar site, and parietal peritoneum of upper abdomen. A frozen examination was 
performed from these deposits. Frozen sections revealed malignant and the patient was accepted as 
peritonitis carcinomatosa. She was discharged on postoperative 3
rd
 day.  
  The patient’s clinical condition was discussed at oncology council and adjuvant chemotherapy 
was recommended. PET-CT examination 6 months after the operation showed a recurrent tumor in 
the operation site. The patient died after twenty months of first surgery. 
Discussion 
Adenocarcinomas constitute more than 80% of gallbladder malignancies. The rate of 
carcinosarcomas is less than 1%. Carcinosarcomas have been generally reported in uterus, lung, 
esophagus, kidney, pancreas, thyroid, and breast [2, 3]. The first case of GBCS was reported by 
Landsteiner in 1907 [10, 11]. Carcinosarcomas are tumors in which mesenchymal and epithelial 
components are found together. Interlaced carcinomatous and sarcomatous areas are noted in this 
malignant tumor. The predominant appearance in epithelial areas is the adenoid formations. Chords 
and layering may also be observed. The sarcomatous component is composed of heterologous 
elements. These areas may have chondrosarcoma, osteosarcoma, and rhabdomyosarcoma features . 
Immunohistochemically, negativity of sarcomatous areas for cytokeratin and carcinoembryonic 
antigen allows differential diagnosis from spindle and giant cell carcinoma [1-5, 8].  
  In our case, cytokeratin was positive in epithelial areas while it was negative in sarcomatous 
areas. A focal staining was evident with smooth muscle actin in sarcomatous areas. In the light of 
these data, our case was considered a carcinosarcoma.  
  A previous review has reported a female-to-male ratio of 3.25/1 and the mean age of diagnosis of 
68.8 years. Two thirds of cases had bile stones [1]. Although our patient was younger than the 
mean age of diagnosis, her features were consistent with the demographic data provided above.   
  Less than 100 cases have been reported in literature so far. Therefore, no staging system has been 
developed and no consensus has been established for its treatment and management [1-3]. On the 
other hand, some authors use AJCCSS (American Joint Committee Cancer Classification System). 
Our patient was staged as Stage 4A (T4N0M0) according to TNM staging [8,9]. The preferred 
treatment option for successful outcomes is usually surgical treatment in limited tumors. No 
successful results have been reported so far with radiotherapy and chemotherapy in more advanced 
tumors [1, 5].  
  The prognosis is usually poor despite aggressive surgical resection. Although hepatic and 
peritoneal involvements are frequent, other abdominal organs and regional lymph nodes were 
detected to be involved in many cases. Many patients have been lost within a couple of months due 
to recurrences and metastases despite successful surgical intervention. A case with no liver invasion 
and lymph node metastasis has been reported to live for 54 months following radical 
cholecystectomy [9]. Curative surgical resection appears to be the only chance for long survival in 
cases with such carcinosarcomas. However, even with radical surgical resection in more widespread 
tumors 3-year survival and median survival have been reported to be only 31.0%, and 7.0 months, 
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respectively [5]. Majority of recurrences develop within the first 6 months after the surgery and the 
mean recurrence time has been reported as 50 days [ 5, 9-11]. 
  Although the majority of the  recent literature data suggest that post -surgical 
chemo-radiotherapy has no survival advantage, our patient was begun on chemotherapy in line with 
the oncology council recommendations. Despite this, she was diagnosed with local recurrences at 
the 6th month of follow-up and chemotherapy was continued. She died after twenty months of first 
surgery. 
  As the prognosis of carcinosarcoma is worse than adenocarcinoma, novel adjuvant chemotherapy 
and/or radiotherapy protocol options should be developed [11].  
  In conclusion, gallbladder carcinosarcomas have very poor survival rate even with successful 
surgical therapy due to unclear ethiopathogenesis, extremely low incidence, and lack of consensus 
regarding its follow-up and treatment. It is important to establish new surgical and adjuvant 
treatment protocols with increasing knowledge and experience as our case added to literature.  
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